Data / Form D filings / InDevR, Inc.
InDevR, Inc.: Form D filings
InDevR, Inc., a biotechnology company in Boulder, CO, filed 2 Form D notices with the SEC between 2019 and 2023. The latest, on January 18, 2023, reports $6 million sold of a $9 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2100 CENTRAL AVENUE, SUITE 105, Boulder, CO, 80301
- Phone
- (303) 402-9100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1787617
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | New notice | $9,000,000 | $5,999,975 | $3,000,025 | 3 | Oct 24, 2022 | sec.gov |
| Sep 10, 2019 | New notice | $6,999,998 | $3,999,998 | $3,000,000 | 1 | Aug 29, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Chang | Director | |
| Shannon Rodriguez | Executive Officer, Director, Promoter | |
| Kathy Rowlen | Executive Officer, Director, Promoter | |
| Michael Reynier | Director | |
| Erica Dawson | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Jan 16, 2023 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what InDevR, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.